Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Bladder Cancer

  Free Subscription


15.07.2019

2 Am J Cancer Res
1 Ann Glob Health
1 Ann Surg Oncol
1 Antioxidants (Basel)
1 Asian J Urol
1 BMJ Open
1 Cancer Discov
1 Cancer Sci
1 Cancers (Basel)
2 Eur Rev Med Pharmacol Sci
4 Eur Urol Oncol
1 FASEB J
1 Front Immunol
2 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 Int J Urol
1 J Cancer
1 J Cell Physiol
1 J Exp Clin Cancer Res
2 J Urol
1 Mil Med
1 Nat Rev Urol
1 Nutr Cancer
5 Oncol Lett
1 Oncologist
1 Urol Case Rep
2 Urol J
1 Urol Oncol
1 Zhongguo Yi Xue Ke Xue Yuan Xue Bao


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cancer Res

  1. ISLAM A, Yang YT, Wu WH, Chueh PJ, et al
    Capsaicin attenuates cell migration via SIRT1 targeting and inhibition to enhance cortactin and beta-catenin acetylation in bladder cancer cells.
    Am J Cancer Res. 2019;9:1172-1182.
    PubMed     Text format     Abstract available

  2. CHAKRABORTY A, Dasari S, Long W, Mohan C, et al
    Urine protein biomarkers for the detection, surveillance, and treatment response prediction of bladder cancer.
    Am J Cancer Res. 2019;9:1104-1117.
    PubMed     Text format     Abstract available


    Ann Glob Health

  3. REZAEI F, Tabatabaee HR, Rahmanian V, Mirahmadizadeh A, et al
    The Correlation Between Bladder Cancer and Obesity, Overweight, Physical Inactivity, and Tobacco Use: An Ecological Study in Asian Countries.
    Ann Glob Health. 2019;85.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  4. LEE J, Jeh SU, Koh DH, Chung DY, et al
    Probe-Based Confocal Laser Endomicroscopy During Transurethral Resection of Bladder Tumors Improves the Diagnostic Accuracy and Therapeutic Efficacy.
    Ann Surg Oncol. 2019;26:1158-1165.
    PubMed     Text format     Abstract available


    Antioxidants (Basel)

  5. MENESES-GUTIERREZ CL, Hernandez-Damian J, Pedraza-Chaverri J, Guerrero-Legarreta I, et al
    Antioxidant Capacity and Cytotoxic Effects of Catechins and Resveratrol Oligomers Produced by Enzymatic Oxidation against T24 Human Urinary Bladder Cancer Cells.
    Antioxidants (Basel). 2019;8.
    PubMed     Text format     Abstract available


    Asian J Urol

  6. GOEL S, Sinha RJ, Bhaskar V, Aeron R, et al
    Role of gemcitabine and cisplatin as neoadjuvant chemotherapy in muscle invasive bladder cancer: Experience over the last decade.
    Asian J Urol. 2019;6:222-229.
    PubMed     Text format     Abstract available


    BMJ Open


  7. Correction: Life and bladder cancer: protocol for a longitudinal and cross-sectional patient-reported outcomes study of Yorkshire (UK) patients.
    BMJ Open. 2019;9:e030850corr1.
    PubMed     Text format    


    Cancer Discov


  8. G9a Inhibition Has Antitumor Activity in Bladder Cancer.
    Cancer Discov. 2019 Jul 12. pii: 2159-8290.CD-RW2019.
    PubMed     Text format     Abstract available


    Cancer Sci

  9. XIAO KH, Teng K, Ye YL, Tan L, et al
    Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via the Akt/GSK3beta signaling.
    Cancer Sci. 2019 Jul 6. doi: 10.1111/cas.14126.
    PubMed     Text format     Abstract available


    Cancers (Basel)

  10. ASHIRU O, Esteso G, Garcia-Cuesta EM, Castellano E, et al
    BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine.
    Cancers (Basel). 2019;11.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  11. DONG ZC, Zhang D, Zhang XX, Yao ZQ, et al
    MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3beta/beta-catenin pathway.
    Eur Rev Med Pharmacol Sci. 2019;23:5682-5690.
    PubMed     Text format     Abstract available

  12. YAN T, Ye XX
    MicroRNA-328-3p inhibits the tumorigenesis of bladder cancer through targeting ITGA5 and inactivating PI3K/AKT pathway.
    Eur Rev Med Pharmacol Sci. 2019;23:5139-5148.
    PubMed     Text format     Abstract available


    Eur Urol Oncol

  13. BOERI L, Soligo M, Frank I, Boorjian SA, et al
    Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes.
    Eur Urol Oncol. 2019;2:390-396.
    PubMed     Text format     Abstract available

  14. LIPUNOVA N, Wesselius A, Cheng KK, van Schooten FJ, et al
    Genome-wide Association Study for Tumour Stage, Grade, Size, and Age at Diagnosis of Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2019;2:381-389.
    PubMed     Text format     Abstract available

  15. COLE AP, Ramaswamy A, Harmouch S, Fletcher SA, et al
    Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference?
    Eur Urol Oncol. 2019;2:349-354.
    PubMed     Text format     Abstract available

  16. GROSSMAN HB, Bellmunt J, Black PC
    Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?
    Eur Urol Oncol. 2019 Jul 3. pii: S2588-9311(19)30077.
    PubMed     Text format     Abstract available


    FASEB J

  17. ZHUANG C, Ma Q, Zhuang C, Ye J, et al
    LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC.
    FASEB J. 2019 Jul 12:fj201900078RR. doi: 10.1096/fj.201900078.
    PubMed     Text format     Abstract available


    Front Immunol

  18. RODRIGUEZ D, Goulart C, Pagliarone AC, Silva EP, et al
    In vitro Evidence of Human Immune Responsiveness Shows the Improved Potential of a Recombinant BCG Strain for Bladder Cancer Treatment.
    Front Immunol. 2019;10:1460.
    PubMed     Text format     Abstract available


    Int J Cancer

  19. STROGGILOS R, Mokou M, Latosinska A, Makridakis M, et al
    Proteome-based classification of Non-Muscle Invasive Bladder Cancer.
    Int J Cancer. 2019 Jul 8. doi: 10.1002/ijc.32556.
    PubMed     Text format     Abstract available

  20. BASSETT JK, Brinkman MT, Dugue PA, Ueland PM, et al
    Circulating concentrations of B group vitamins and urothelial cell carcinoma.
    Int J Cancer. 2019;144:1909-1917.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  21. ALI A, Song YP, Mehta S, Mistry H, et al
    Palliative radiotherapy in bladder cancer - importance of patient selection: A retrospective multicenter study.
    Int J Radiat Oncol Biol Phys. 2019 Jul 5. pii: S0360-3016(19)33441.
    PubMed     Text format     Abstract available


    Int J Urol

  22. TOIDE M, Yokoyama M, Fujiwara M, Kijima T, et al
    Renal function after bladder-preserving therapy for patients with muscle-invasive bladder cancer: Results of selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cyst
    Int J Urol. 2019 Jul 8. doi: 10.1111/iju.14054.
    PubMed     Text format    


    J Cancer

  23. KIM TJ, Moon HW, Kang S, Yang J, et al
    Urovysion FISH Could Be Effective and Useful Method to Confirm the Identity of Cultured Circulating Tumor Cells from Bladder Cancer Patients.
    J Cancer. 2019;10:3259-3266.
    PubMed     Text format     Abstract available


    J Cell Physiol

  24. SHAN G, Tang T, Xia Y, Qian HJ, et al
    MEG3 interacted with miR-494 to repress bladder cancer progression through targeting PTEN.
    J Cell Physiol. 2019 Jul 11. doi: 10.1002/jcp.29025.
    PubMed     Text format     Abstract available


    J Exp Clin Cancer Res

  25. RICHTER C, Marquardt S, Li F, Spitschak A, et al
    Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
    J Exp Clin Cancer Res. 2019;38:292.
    PubMed     Text format     Abstract available


    J Urol

  26. CHANG SS
    Re: Population-Based Assessment of Racial/Ethnic Differences in Utilization of Radical Cystectomy for Patients Diagnosed with Bladder Cancer.
    J Urol. 2019 Jul 9:10109701JU0000576988055492.
    PubMed     Text format    

  27. ATALA A
    Re: Mouse and Human Urothelial Cancer Organoids: A Tool for Bladder Cancer Research.
    J Urol. 2019 Jul 9:10109701JU000057698421354.
    PubMed     Text format    


    Mil Med

  28. CAPUTO JM, Moran G, Muller B, Keller AT, et al
    The Management of Newly-Diagnosed Non-muscle Invasive Bladder Cancer in Veterans Integrated Services Network 02 of the Veterans Health Administration.
    Mil Med. 2019 Jul 11. pii: 5531171. doi: 10.1093.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  29. ALIFRANGIS C, McGovern U, Freeman A, Powles T, et al
    Molecular and histopathology directed therapy for advanced bladder cancer.
    Nat Rev Urol. 2019 Jul 9. pii: 10.1038/s41585-019-0208.
    PubMed     Text format     Abstract available


    Nutr Cancer

  30. WU J, Yu Y, Huang L, Li Z, et al
    Dairy Product Consumption and Bladder Cancer Risk: A Meta-Analysis.
    Nutr Cancer. 2019 Jul 11:1-9. doi: 10.1080/01635581.2019.1637909.
    PubMed     Text format     Abstract available


    Oncol Lett

  31. LUCCA I, Hofbauer SL, Haitel A, Susani M, et al
    Urinary expression of genes involved in DNA methylation and histone modification for diagnosis of bladder cancer in patients with asymptomatic microscopic haematuria.
    Oncol Lett. 2019;18:57-62.
    PubMed     Text format     Abstract available

  32. LIU C, Ge M, Ma J, Zhang Y, et al
    Homeobox A10 promotes the proliferation and invasion of bladder cancer cells via regulation of matrix metalloproteinase-3.
    Oncol Lett. 2019;18:49-56.
    PubMed     Text format     Abstract available

  33. CHEN Z, Du Y, Liu X, Chen H, et al
    EZH2 inhibition suppresses bladder cancer cell growth and metastasis via the JAK2/STAT3 signaling pathway.
    Oncol Lett. 2019;18:907-915.
    PubMed     Text format     Abstract available

  34. RAJA SA, Shah STA, Tariq A, Bibi N, et al
    Caveolin-1 and dynamin-2 overexpression is associated with the progression of bladder cancer.
    Oncol Lett. 2019;18:219-226.
    PubMed     Text format     Abstract available

  35. YU Z, Xu Q, Wang G, Rowe M, et al
    DNA topoisomerase IIalpha and RAD21 cohesin complex component are predicted as potential therapeutic targets in bladder cancer.
    Oncol Lett. 2019;18:518-528.
    PubMed     Text format     Abstract available


    Oncologist

  36. MERTEN R, Ott O, Haderlein M, Bertz S, et al
    Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2).
    Oncologist. 2019 Jul 10. pii: theoncologist.2018-0280.
    PubMed     Text format     Abstract available


    Urol Case Rep

  37. ALANEE S
    Pyeloduodenal fistula complicating neoadjuvant chemotherapy in a patient diagnosed with muscle invasive bladder cancer.
    Urol Case Rep. 2019;26:100931.
    PubMed     Text format     Abstract available


    Urol J

  38. DEVRIM T, Atac F, Altunkaya C, Ozbek A, et al
    Rare Plasmacytoid Urothelial Carcinoma of the Bladder: Two Case Reports.
    Urol J. 2019;16:86-88.
    PubMed     Text format     Abstract available

  39. DAGLI R, Dadali M, Emir L, Bagbanci S, et al
    Comparison of Classic and Inguinal Obturator Nerve Blocks Applied for Preventing Adductor Muscle Contractions in Bladder Tumor Surgeries: A Prospective Randomized Trial.
    Urol J. 2019;16:62-66.
    PubMed     Text format     Abstract available


    Urol Oncol

  40. KAWADA T
    Risk assessment of bladder cancer: lifestyle and nutritional contribution.
    Urol Oncol. 2019 Jul 4. pii: S1078-1439(19)30222.
    PubMed     Text format    


    Zhongguo Yi Xue Ke Xue Yuan Xue Bao

  41. ZHANG WY, Wang HR, Hu H, Wang Q, et al
    [Clinical Features and Diagnosis of Encrusted Bladder Cancer].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:430-434.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: